BELLANTI, FRANCESCO
 Distribuzione geografica
Continente #
EU - Europa 6.518
NA - Nord America 6.185
AS - Asia 4.126
SA - Sud America 519
AF - Africa 69
Continente sconosciuto - Info sul continente non disponibili 22
OC - Oceania 7
Totale 17.446
Nazione #
US - Stati Uniti d'America 6.063
SG - Singapore 1.455
CN - Cina 1.385
IT - Italia 1.366
IE - Irlanda 1.356
RU - Federazione Russa 831
UA - Ucraina 812
SE - Svezia 730
BR - Brasile 434
HK - Hong Kong 381
FR - Francia 376
DE - Germania 349
FI - Finlandia 237
IN - India 231
VN - Vietnam 223
TR - Turchia 174
GB - Regno Unito 145
AT - Austria 78
CA - Canada 63
BD - Bangladesh 51
NL - Olanda 40
MX - Messico 38
BE - Belgio 33
ES - Italia 33
PL - Polonia 33
AR - Argentina 30
CZ - Repubblica Ceca 28
JP - Giappone 28
IQ - Iraq 27
ID - Indonesia 25
ZA - Sudafrica 25
EU - Europa 18
PK - Pakistan 18
AE - Emirati Arabi Uniti 17
SA - Arabia Saudita 15
CH - Svizzera 13
CO - Colombia 11
IR - Iran 11
KR - Corea 11
VE - Venezuela 11
CL - Cile 10
EC - Ecuador 10
LT - Lituania 10
UZ - Uzbekistan 10
JO - Giordania 9
KE - Kenya 9
AL - Albania 8
PH - Filippine 8
TN - Tunisia 8
EG - Egitto 7
KZ - Kazakistan 7
RO - Romania 7
IL - Israele 6
MA - Marocco 6
HU - Ungheria 5
JM - Giamaica 5
MY - Malesia 5
PY - Paraguay 5
RS - Serbia 5
AU - Australia 4
AZ - Azerbaigian 4
DZ - Algeria 4
HN - Honduras 4
LV - Lettonia 4
BO - Bolivia 3
GR - Grecia 3
NP - Nepal 3
NZ - Nuova Zelanda 3
PA - Panama 3
PE - Perù 3
PS - Palestinian Territory 3
TH - Thailandia 3
TT - Trinidad e Tobago 3
BG - Bulgaria 2
CI - Costa d'Avorio 2
CR - Costa Rica 2
DK - Danimarca 2
GE - Georgia 2
KG - Kirghizistan 2
LB - Libano 2
MM - Myanmar 2
MT - Malta 2
SI - Slovenia 2
SN - Senegal 2
SY - Repubblica araba siriana 2
TW - Taiwan 2
UY - Uruguay 2
XK - ???statistics.table.value.countryCode.XK??? 2
A1 - Anonimo 1
A2 - ???statistics.table.value.countryCode.A2??? 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BH - Bahrain 1
BY - Bielorussia 1
CM - Camerun 1
GA - Gabon 1
GT - Guatemala 1
KW - Kuwait 1
LK - Sri Lanka 1
LU - Lussemburgo 1
Totale 17.434
Città #
Dublin 1.356
San Jose 1.216
Singapore 728
Chandler 648
Jacksonville 554
Nyköping 482
Ashburn 399
Hong Kong 374
Dearborn 342
Beijing 300
Dallas 265
Nanjing 238
Santa Clara 212
Lauterbourg 157
Wilmington 152
New York 143
Princeton 133
Nanchang 114
Moscow 108
Rome 106
Helsinki 105
Munich 105
San Mateo 95
Ho Chi Minh City 92
Ann Arbor 91
The Dalles 89
Boardman 73
Vienna 72
Milan 69
Bari 64
Shenyang 64
Foggia 57
Woodbridge 54
Tianjin 53
Los Angeles 50
Kunming 46
São Paulo 45
Hebei 41
Turku 41
Hanoi 38
Jiaxing 36
Des Moines 34
Brussels 33
Changsha 32
Hangzhou 32
Frankfurt am Main 31
Jinan 30
Houston 28
Toronto 28
Stevenage 27
Shanghai 25
Delhi 24
Naples 24
Redwood City 24
Council Bluffs 23
Tokyo 23
Zhengzhou 23
London 22
Ningbo 22
Seattle 22
Brno 20
Guangzhou 20
Hilden 19
Warsaw 18
Florence 17
Pune 17
Rio de Janeiro 17
San Francisco 17
Assago 16
Brooklyn 15
Norwalk 15
Palermo 15
Chennai 14
Jakarta 14
Orem 14
Atlanta 13
Bologna 13
Caserta 13
Mola Di Bari 13
Wuhan 13
Belo Horizonte 12
Chicago 12
Fuzhou 12
Hillsboro 12
Baghdad 11
Barcelona 11
Haiphong 11
Montreal 11
Paris 11
San Severo 11
Turin 11
Johannesburg 10
Kraków 10
Orange 10
Padova 10
Taizhou 10
Augusta 9
Charlotte 9
Nairobi 9
Stockholm 9
Totale 10.438
Nome #
Effetti della sarcopenia e dell’obesità sarcopenica sul rischio cardiovascolare 846
Effetti dell’associazione tra malnutrizione e sarcopenia sulla composizione corporea 280
A silybin-phospholipid vitamin E complex (siliphos) limits the hepatic damage and reduces oxidative stress in human obesity – related liver disease. 207
Aging e disaccoppiamento mitocondriale: diverso effetto sulla produzione di radicali liberi in tessuti mitotici e post-mitotici. 201
A silybin-phospholipid-vitamin E complex (SILIPHOS) prevents oxidation of UCP2 and limits mitochondrial dysfunction during non-alcoholic steatohepatitis. 197
Liver toxicity induced by amiodarone is dependent on mitochondria Complex I impairment, OXPHOS uncoupling and cardiolipin peroxidation. 181
Effetti del diabete mellito tipo 2 sulla composizione corporea dei pazienti sarcopenici 175
Aging e disaccoppiamento mitocondriale: diverso effetto sulla produzione di radicali liberi in tessuti mitotici e post-mitotici. 167
Alteration of fatty acid beta-oxidation observed in severe steatosis depends on CPT1 impairment and change in mitochondrial membrane lipid composition. 166
Disaccoppiamento mitocondriale in corso di Steatoepatite Non Alcolica 163
DAAs rapidly reduce inflammation but increase serum VEGF level: A rationale for tumor risk during anti-HCV treatment 162
Adherence to Mediterranean Diet, Malnutrition, Length of Stay and Mortality in Elderly Patients Hospitalized in Internal Medicine Wards 160
A silybin-phospholipid complex prevents mitochondrial dysfunction in a rodent model of nonalcoholic steatohepatitis 157
Meccanismi del danno ed effetti protettivi di exenatide in un modello sperimentale di ischemia/riperfusione cerebrale 155
A Silybin-phospholipid Complex Prevents Mitochondrial Oxidative Stress in Models of Chronic Liver Disease. 151
Alterations of Clock Gene RNA Expression in Brain Regions of a Triple Transgenic Model of Alzheimer’s Disease 151
UCP2 overexpression sensitizes NASH liver to ischemia/reperfusion injury by increasing mitochondrial proton leak. 150
Alterations of hepatic ATP homeostasis and respiratory chain during development of non-alcoholic steatohepatitis in a rodent model 149
Il complesso silibina-fosfolipidi-vitamina E normalizza l’ipertransaminasemia in soggetti affetti da steatosi epatica non alcolica. 148
Uncoupling protein-2 (UCP2) induces mitochondrial proton leak and increases susceptibility of non-alcoholic steatohepatitis (NASH) liver to ischaemia-reperfusion injury 146
A silybin-phospholipids-vitamin E complex (siliphos) reduces oxidative stress in patients affected by non-alcoholic hepatic steatosis. 145
Disaccoppiamento mitocondriale in corso di Steatoepatite Non Alcolica 143
DAAs increase serum VEGF level: a rationale for tumour risk recurrence during anti-HCV treatment 142
Oxidative stress is increased in sarcopenia and associated with cardiovascular disease risk in sarcopenic obesity (Q1 WoS) 141
A silybin-phospholipid-vitamin E complex reduces mitochondrial oxidative stress in a rodent model of chronic cholestasis. 139
N-acetylcysteine prevents amiodarone-induced inhibition of Complex I, OXPHOS uncoupling and cardiolipin peroxidation in rat liver mitochondria. 138
Diagnostic reliability of the procalcitonin serum marker in septic frail patient 138
Analisi della bioenergetica mitocondriale in corso di Ischemia/Riperfusione renale e ruolo protettivo del postcondizionamento ischemico. 137
Alterazioni bioenergetiche mitocondriali durante lo sviluppo della Steatoepatite Non Alcolica 134
Bioenergetics in aging: mitochondrial proton leak in aging rat liver, kidney and heart 133
Oxidative stress and aging. 133
Principles and therapeutic relevance for targeting mitochondria in aging and neurodegenerative diseases. 133
Exenatide e gli inibitori di DPP-4 sono efficaci nel trattamento della neuropatia sensitiva associata a diabete mellito tipo II in pazienti anziani 131
Amiodarone induces liver toxicity by impairing liver mitochondria bioenergetics and redox balance. 130
UCP2 increase the sensibilità to liver ischemia/reperfusion injury in a NASH model. 130
Oxidation of Carnitine Palmitoyl Transferase 1 alters fatty acid metabolism in a rodent model of nonalcoholic steatohepatitis. 129
Mitochondria peroxide synthesis and CPT-1 nitrosylation durino NASH development: a model of oxidative stress disease 129
UCP2 induces mitochondrial uncoupling during nonalcoholic steatohepatitis: An adaptative mechanism to reduce oxidative stress but producing depletion of ATP 129
Effects of dietary fatty acids and cholesterol excess on liver injury: a lipidomic approach 129
CPT-1 is a key target of mitochondria nitrosylation during NASH development 128
Alterazioni della bioenergetica mitocondriale in un modello animale di ipoperfusione cerebrale cronica. 127
THE ROLE OF TRANSIENT ELASTOGRAPHY (FIBROSCAN) IN THE STUDY OF LIVER FIBROSIS IN SSc 127
A myoferlin gain-of-function variant associates with a new type of hereditary angioedema 127
Mitochondrial Oxidative Stress is an Early Event in Amiodarone Hepatotoxicity, Inducing Complex I Impairment and Cardiolipin Peroxidation. 126
Lo stress ossidativo e la disfunzione mitocondriale nella NASH causano l’attivazione del PTP inducendo l’apoptosi. 126
Transarterial chemoembolization vs bland embolization in hepatocellular carcinoma: A meta-analysis of randomized trials 125
Ultramicronized palmitoylethanolamide rescues learning and memory impairments in a triple transgenic mouse model of Alzheimer's disease by exerting anti-inflammatory and neuroprotective effects 125
Lo stress ossidativo e la disfunzione mitocondriale nella NASH causano l’attivazione del PTP inducendo l’apoptosi. 124
MITOCHONDRIAL DYSFUNCTIONS IN A TRANSGENIC MURINE MODEL OF ALZHEIMER’S DISEASE 124
Disfunzione mitocondriale in differenti aree cerebrali in un modello transgenico di Alzheimer. 124
Oxidation of Hepatic Carnitine Palmitoyl Transferase-I (CPT-I) Impairs Fatty Acid Beta-Oxidation in Rats Fed a Methionine-Choline Deficient Diet. 123
Il postcondizionamento renale protegge il rene dal danno da ischemia riperfusione attraverso l’inibizione del mitchondrial permeabilità transitino pore. 122
La supplementazione di silibina e vitamina E (silyphos) previene la disfunzione mitocondriale osservata nella steatoepatite non alcolica. 122
Combined Effects of 2 Interleukin 28B Polymorphisms on the Therapeutic Outcome of Hepatitis C Patients with Circulating Cryoglobulins 122
UCP2 increase the sensibility to liver ischemia/reperfusion injury in a NASH model. 120
Polimorfismi del gene della Glutatione S-Trasferasi Omega -1: analisi del linkage disequilibrium fra i polimorfismi Ala140Asp E Glu155ΔGlu dell’esone 4 e interazione con l’ApoE in una popolazione di centenari pugliesi 120
Cerebral oligoemia induces mitochondria dysfunction and increase in hydroperoxide production in a chronic rat model of vascular dementia. 119
Efficacy and safety of direct-acting antivirals in elderly with chronic hepatitis C: results from a retrospective cohort study 118
Propofol but not sevoflurane prevents mitochondrial dysfunction and oxidative stress by limiting HIF-1α activation in hepatic ischemia/reperfusion injury (Q1 WoS) 115
Mitochondrial Signaling and Hepatocellular Carcinoma: Molecular Mechanisms and Therapeutic Implications 115
Glutamatergic alterations and mitochondrial impairment in a murine model of Alzheimer disease 115
Nella steatoepatite indotta da amiodarone le alterazioni della funzione mitocondriale precedono la steatosi e la necrosi e suggeriscono nuove strategie di intervento terapeutico. 114
Studio delle alterazioni comportamentali e istologiche in un modello animale di oligoemia cerebrale cronica. 112
Reactive Oxygen Species (ROS) and liver disease therapy 112
Oxysterols induce mitochondrial impairment and hepatocellular toxicity in non-alcoholic fatty liver disease 111
Changes in circulating redox bilance and increased markers of oxidative stress predict Frailty condition: the “Oxidative Frailty Syndrome”. 111
Rat brain bioenergetics is impaired in a two-vessel occlusion model of vascular dementia. 110
Oxidative stress and mitochondrial dysfunction are associated with the opening of permeability transition pore in a rodent model of NAFLD. 110
Comparison of Three Nutritional Screening Tools with the New Glim Criteria for Malnutrition and Association with Sarcopenia in Hospitalized Older Patients 109
Oxysterols in the orchestra of liver cell metabolism 107
Disfunzione mitocondriale in differenti aree cerebrali di ratti senescenti: importanza dell'assessment bioenergetico. 106
Lipid oxidation products in the pathogenesis of non-alcoholic steatohepatitis 106
Mitochondrial activity in NASH pathogenesis: role of respiratory chain and fatty acids transport 105
Direct-acting antivirals restore systemic redox homeostasis in chronic HCV patients (Q1 WoS) 105
Molecular Aspects and Treatment of Iron Deficiency in the Elderly 105
NASH induces expression of UCP2 and mitochondria respiratory impairment in liver hepatocytes 104
Mitochondrial involvement in non-alcoholic steatohepatitis 104
Inhibition of nuclear factor (erythroid-derived 2)-like 2 promotes hepatic progenitor cell activation and differentiation (Q1 WoS) 104
Malnutrition in Hospitalized Old Patients: Screening and Diagnosis, Clinical Outcomes, and Management 104
A Novel Nutraceuticals Mixture Improves Liver Steatosis by Preventing Oxidative Stress and Mitochondrial Dysfunction in a NAFLD Model 103
Mitochondrial proton leak during aging: ditferent effect on free radicals production in mitotic and postmitotic tissues. 102
An Amino Acid Mixture to Counteract Skeletal Muscle Atrophy: Impact on Mitochondrial Bioenergetics (Q1 WoS) 99
Disfunzione mitocondriale in differenti aree cerebrali di ratti senescenti: importanza dell’assessment bioenergetico. 99
Treatment of chronic HCV infection in the era of protease inhibitors 99
Blood Magnesium Level and Selected Oxidative Stress Indices in Lead-Exposed Workers 98
Changes in circulating redox balance and increased markers of oxidative stress predict Frailty condition: the "Oxidative Frailty Syndrome'' 98
PROPOFOL, BUT NOT SEVORANE, PROTECTS MITOCHONDRIA AND LIVER FUNCTION AFTER ISCHEMIA-REPERFUSION INJURY 97
PROPOFOL, BUT NOT SEVORANE, PROTECTS MITOCHONDRIA AND LIVER FUNCTION AFTER ISCHEMIA-RIPERFUSION INJURY 97
HNE induces UCP2 expression and proton leak to limit oxidative stress but reduces ATP synthesis in non-alcoholic steatohepatitis. 93
Frailty syndrome is associated with altered circulating redox balance and increased markers of oxidative stress 93
Mitochondrial oxidative stress and respiratory chain dysfunction account for liver toxicity during amiodarone but not dronedarone administration. 93
Renal postconditioning: a novel mechanism in the prevention of I/R damage. 92
Free radical biology for medicine: learning from nonalcoholic fatty liver disease. 92
Effect of sevoflurane and propofol anaesthesia on mitochondria and postoperative hepatocellular injury in steatotic patients: preliminary data: 9AP5‐7 91
An open-label, single-center pilot study to test the effects of an amino acid mixture in older patients admitted to internal medicine wards 90
La supplementazione di silibina e vitamina E (silyphos) previene la disfunzione mitocondriale osservata nella steatoepatite non alcolica. 90
Mitochondrial dysfunction in nonalcoholic steatohepatitis. 89
Prognostic factors for anastomotic urinary leakage following retropubic radical prostatectomy and correlation with voiding outcomes 88
Redox cell signaling and hepatic progenitor cells 88
Adherence to the Mediterranean Diet Mitigates Inflammation and Hospital Stay in Frail Elderly Patients: A Moderation Analysis (Q1 WoS) 87
Totale 13.286
Categoria #
all - tutte 90.784
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 90.784


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202134 0 0 0 0 0 0 0 0 0 0 0 34
2021/20221.030 119 12 23 16 98 40 51 110 123 102 83 253
2022/20233.270 331 171 151 157 176 280 40 265 1.501 35 65 98
2023/2024807 96 44 38 47 47 213 29 43 13 18 56 163
2024/20252.874 161 76 122 134 128 348 286 133 680 184 303 319
2025/20265.272 351 354 575 621 346 236 1.168 606 299 409 146 161
Totale 18.104